This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
The phase for this study is not defined.
Show me locations

The purpose

The primary objective of this specimen correlative study is two-fold: to provide a mechanism for the association of known molecular alterations with clinical outcomes, and to provide rapid genetic profiling of alterations with known clinical utility using tumor and germline specimens to support treatment decisions.

Provided treatments

  • DiagnosticTest: Tumor Genetic Sequencing

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01457196. The sponsor of the trial is UNC Lineberger Comprehensive Cancer Center and it is looking for 2798 volunteers for the current phase.
Official trial title:
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions